Ann Hsu
- Virology top 0.1%
- HIV Research and Treatment 29
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 35
- HIV/AIDS Research and Interventions 10
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 8
- Hepatology top 2%
- Pharmacology top 1%
-
- Parkinson's Disease Mechanisms and Treatments 17
- Neurological disorders and treatments 13
-
- Autism Spectrum Disorder Research 11
-
- Erythrocyte Function and Pathophysiology 6
- Co-authors
- G. Richard GrannemanJohn M. LeonardRichard BertzDale J. KempfEugene SunDavid D. HoMartin MarkowitzJoaquin Valdes
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)Neurology (5 papers)Clinical Pharmacology & Therapeutics (5 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ann Hsu
65 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Virology 2.7k
- Infectious Diseases 3.5k
- Emergency Medicine 866
- Hepatology 392
- Pharmacology 385
Countries citing papers authored by Ann Hsu
This map shows the geographic impact of Ann Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Hsu more than expected).
Fields of papers citing papers by Ann Hsu
This network shows the impact of papers produced by Ann Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Hsu. The network helps show where Ann Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 3 | |
| 2 | 2016 | 4 | |
| 3 | 2015 | 57 | |
| 4 | 2015 | 18 | |
| 5 | 2014 | 53 | |
| 6 | 2013 | 5 | |
| 7 | 2003 | 5 | |
| 8 | 2003 | 102 | |
| 9 | Assessment of the steady-state pharmacokinetic interaction of lopinavir/ritonavir with either indinavir or saquinavir in healthy subjects | 2002 | 5 |
| 10 | 2001 | 14 | |
| 11 | 2001 | 61 | |
| 12 | Assessment of the bioequivalence and food effects for liquid and soft elastic capsule co-formulations of ABT-378/ritonavir in healthy subjects | 2000 | 8 |
| 13 | Assessment of the pharmacokinetic interaction between ABT-378/ritonavir and efavirenz in healthy volunteers and in HIV + subjects | 2000 | 1 |
| 14 | 1998 | 64 | |
| 15 | 1998 | 54 | |
| 16 | 1998 | 143 | |
| 17 | 1998 | 10 | |
| 18 | Ordered accumulation of mutations in HIV protease confers resistance to ritonavirbreakdown → | 1996 | 601 |
| 19 | 1995 | 403 | |
| 20 | 1995 | 472 |
About Ann Hsu
Ann Hsu is a scholar working on Virology, Infectious Diseases, Neurology, Emergency Medicine and Hepatology, having authored 67 papers that have together received 5.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (35 papers), HIV Research and Treatment (29 papers), Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (13 papers), Autism Spectrum Disorder Research (11 papers), HIV/AIDS Research and Interventions (10 papers), HIV-related health complications and treatments (8 papers) and Erythrocyte Function and Pathophysiology (6 papers). The work is most often cited by research in Virology (2.7k citations), Infectious Diseases (3.5k citations), Emergency Medicine (866 citations), Hepatology (392 citations) and Pharmacology (385 citations). Ann Hsu has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include G. Richard Granneman, John M. Leonard, Richard Bertz, Dale J. Kempf, Eugene Sun, David D. Ho, Martin Markowitz, Joaquin Valdes, Suneel Gupta and Charles A. Boucher. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Neurology, Clinical Pharmacology & Therapeutics, AIDS and Blood Cells Molecules and Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.